Postpartum Depression

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

What is new in research on postpartum depression?

Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

How can psychiatric clinicians improve outcomes for this unique patient population?

Neurosteroid therapeutics could be the solution to provide fast-acting treatment for mothers with postpartum depression.

The FDA did not grant approval for the treatment for major depressive disorder.

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.